AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
Anavex's A2-73 Blarcamesine's trial result... See more
Mar, 20, 2023
Complete Results!! !
XERS
Xeris Biopharma Holdings Inc
15.52%
$1.16 - $1.34
Feb 7th 2023 - Mar 21st 2023
Mar, 7, 2023
Add at least 2.5M this quarter and $6 M sometime n... See more
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 21, 2023
Anavex's A2-73 Blarcamesine's trial results on 2 previously completed adult phase-3 trials were highly successful.
Mar, 20, 2023
Complete Results!! !
Mar, 16, 2023
But the company actually has never seen before wonderful results.
Feb, 26, 2023
If results hold up, the stock will achieve massive gains.
Feb, 26, 2023
The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.
Feb, 14, 2023
Alzheimer's is the most valuable and most difficult indication and most desired lately.. and only Anavex really has some great results with a great safety record. .
Jan, 24, 2023
The sava results trounce you guys 🤦🏻♂️🤦🏻♂️🤦🏻♂️😂😂😂
Jan, 24, 2023
Sava has potential and the phase 3 results will show the truth.
Jan, 24, 2023
Sava has good results. .
Mar, 16, 2023
But the company actually has never seen before wonderful results.
Mar, 9, 2023
And, make no mistake, the result are impressive.
Feb, 1, 2023
It is the best results that have been seen in AD.
Jan, 30, 2023
Overall, results impressive.
Jan, 23, 2023
This could be huge in eliminating artificial FUD against the top-line results.
Jan, 13, 2023
$SAVA Market is moving higher as SAVA is expecting data results.
Jan, 9, 2023
Anavex is late like the sun comes up and still produces great results.
Jan, 7, 2023
MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word "Thrilled" in Dec 6 PR.
Mar, 7, 2023
Add at least 2.5M this quarter and $6 M sometime next year, plus Tetris could be up to 71M over time. !
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
Likely doubling/parabolic growth like last 2 quarters.
Mar, 3, 2023
$XERS Gvoke is up 6.6% compared to last quarter (1832 scripts).
Feb, 20, 2023
$XERS @Brodman vs Fintxwizard re Xeris.. And I guarantee that the 4th Quarter 2022 will be a beat and Sales will be at $109.50mm.